Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference View Full Press Release Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Travere Therapeutics Provides Corporate Update and 2026 Outlook